Clinical Trial Update: A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating belvarafenib as a single agent and in combination with cobimetinib or cobimetinib plus nivolumab in NRAS-mutant advanced mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Belvarafenib (belvarafenib)
• Cobimetinib (cobimetinib)
• nivolumab (nivolumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING